Larry Edwards

Larry Edwards joined the Board of Directors in March of 2021. Mr. Edwards has served as a director, President and Chief Executive Officer of La Jolla Pharmaceutical Company since 2020. From 2015 to 2020, he served in various positions at Tetraphase Pharmaceuticals, Inc., most recently serving as Chief Executive Officer. Previously, Mr. Edwards served as Senior Director of Marketing of the Gram-negative Franchise of Cubist Pharmaceuticals, Inc. (acquired by Merck), and multiple ascending leadership roles during more than 15 years at Merck. Mr. Edwards received a B.S. degree in business and healthcare administration from Ohio University.